Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8511-8520 of 13616

Page
per page
  1. Piericidin A
    C3535 Piericidin A
    Summary: mitochondrial complex I inhibitor
      10 mg/mL
  2. Bromoenol lactone
    C5081 Bromoenol lactone
    Summary: Inhibitor of myocardial cytosolic calcium-independent phospholipase A2 (iPLA2)
      ≤2 mg/mL
  3. β-Glycerophosphate (sodium salt hydrate)
    C4347 β-Glycerophosphate (sodium salt hydrate)
     8 Citation
    Summary: protein phosphatase inhibitor
      insoluble in EtOH; ≥14.3 mg/mL
  4. NS3694
    C4468 NS3694
    Summary: inhibits apoptosome formation and caspase activation
      ≥46 mg/mL
  5. KP372-1
    C5053 KP372-1
    Summary: specific Akt inhibitor
      ≤20 mg/mL
  6. T 0156 hydrochloride
    B5162 T 0156 hydrochloride
    Summary: inhibitor of phosphodiesterase type 5 (PDE5)
      <14.59 mg/mL
  7. ICA 121431
    B5802 ICA 121431
    Summary: human NaV1.3 and NaV1.1 channels inhibitor
      Soluble in DMSO
  8. GNE-477
    B8001 GNE-477
    Summary: dual PI3K/mTOR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥16.69 mg/mL
  9. Spautin-1
    B5873 Spautin-1
     1 Citation
    Target: Deubiquitinating enzymes (DUBs)|Autophagy
    Summary: Novel autophagy inhibitor
      insoluble in H2O; ≥13.5 mg/mL
  10. Retigabine
    B5888 Retigabine
    Summary: An activator of voltage-gated potassium channel, used as an anticonvulsant agent

Items 8511-8520 of 13616

Page
per page